AGP Picks
View all

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on November 11, 2026

PETVIVO HOLDINGS TO FILE QUARTERLY REPORT ON NOVEMBER 13, 2026; WELCOMES SHAREHOLDER QUESTIONS AND DIALOGUE
MD Logic Health x Blu Vitals Launch First Collaboration Product, Mag 9+, a Breakthrough Nine-Form Magnesium Complex
Top Linear Actuators Manufacturer Advancing Intelligent Motion Technology
Vocare Trains Care Worker Speech AI In-House on GIGABYTE AI TOP ATOM From XENON
No Veteran Should Feel Forgotten: Comfort Keepers Rallies North Georgia to Grant Wishes for Local Heroes
Moorpark Dental Practice Offers Sunday Hours for Busy Ventura County Families
Join Luma Named Cheapest Place to Buy Compounded Tirzepatide Online Among Seven Providers Compared for 2026
Top 10 Industrial Touch Display Module Manufacturers in 2026: Advancing Custom Curved Displays
Cloud-Clone’s 14 Antibodies Support New Rheumatoid Arthritis Therapy Mechanism Published in ACS Nano
Purity vs. Bioactivity: Cloud‑Clone Active Recombinant Proteins Validated by High‑Impact Publications
Banner Health generates $25.3 billion in annual economic output for Arizona
Whitecap Care’s Autism First Joins National Integrated Therapy Provider
Channel Medsystems Announces Grant Support for an Investigator-Sponsored Clinical Study Evaluating Cerene® Cryotherapy for Women With Adenomyosis
Revenue Cycle Management Market to worth USD 132.06 Billion by 2031, at a CAGR of 12.4% – MarketsandMarkets™
Longevitix Expands AI Clinical Intelligence Platform to Address Gaps in Women’s Preventive Health
Ballipinar Dental Clinic to Bring Oral Health Advice to UK Patients During Mouth Cancer Action Month
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research
NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding
Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D Candidate

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.